Absci Corporation Common Stock

ABSI XNAS • SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

990M

Short interest (May 15)

20.7%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.54%

↑ 0.6%

Available Shares

↑ 7.0%

Price Chart

Company Overview

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Company Info

Exchange: NASDAQ

Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

CIK: 0001672688

Asset Type: CS

Market Data

Market Cap: $989,997,105

Employees: 140

Status: Active

Short Interest

Current Borrow Fee 0.54%

Range: 0.54% - 0.65%

Available Shares 2M

Range: 1.5M - 2.5M

Recent Changes

Fee Change: ↑ 6.8%

Available Change: ↑ 13.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime